Drugs / Swine A/H1N1 influenza vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00956202 | Aug 2009 → Sep 2010 | swine influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Swine A/H1N1 influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00956202 ↗ |
| Modality | Vaccine | “Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Vaccine” NCT00956202 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular on Day 0 and Day 21” NCT00956202 ↗ |